Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Inozyme Pharma, Inc. (INZY) had Weighted-Average Shares Outstanding (Diluted) of 62.81M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-102.02M |
|
-- |
|
-- |
|
$104.03M |
|
$-104.03M |
|
$2.01M |
|
$-102.02M |
|
$-102.02M |
|
$-102.02M |
|
$-102.02M |
|
$-102.02M |
|
$-102.02M |
|
$-104.03M |
|
$-108.33M |
|
62.81M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
62.81M |
$-1.62 |
|
$-1.62 |
|
| Balance Sheet Financials | |
$120.68M |
|
$0.78M |
|
$2.51M |
|
$123.18M |
|
$33.90M |
|
$31.46M |
|
$31.46M |
|
$65.36M |
|
$57.83M |
|
$57.83M |
|
$57.83M |
|
64.24M |
|
| Cash Flow Statement Financials | |
$-91.91M |
|
$67.00M |
|
$11.40M |
|
$34.90M |
|
$21.39M |
|
$-13.51M |
|
$7.95M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.56 |
|
-- |
|
-- |
|
0.35 |
|
0.79 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-91.97M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-176.43% |
|
-176.43% |
|
-82.82% |
|
-114.27% |
|
$0.90 |
|
$-1.46 |
|
$-1.46 |
|